英威騰(002334.SZ):網能公司擬獲450萬元增資
格隆匯5月12日丨英威騰(002334.SZ)公佈,深圳市英威騰網能技術有限公司(簡稱“網能公司”)為公司全資子公司深圳市英威騰電源有限公司(簡稱“電源公司”)的控股子公司,為了更好地促進網能公司健康高速發展,電源公司與網能公司核心管理團隊、核心研發人員擬以貨幣方式向網能公司增資人民幣450萬元,其中300萬元計入網能公司註冊資本,150萬元計入網能公司資本公積。網能公司股東田華臣、張清、尤勇、楊成林、劉兆燊同意放棄該次增資權利。該次交易完成之後,網能公司註冊資本由人民幣2000萬元增加至2300萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.